EUVIMEDEUVIMED entdecken
Crossref

Our Practice Newsletter : By Pharmacists For Pharmacists. Issue 32

Nicole Domański, Barbara Gobis

cIRcle (University of British Columbia) · 01.01.2023

DOI: 10.14288/1.0437498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift cIRcle (University of British Columbia), erschienen am 01.01.2023. Verfasst von Nicole Domański und 1 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Feature Case: Who said what with NSAIDs: Achieving benefit and mitigating risk in the case of possible microscopic colitis. While drug therapy risk cannot be completely eliminated, pharmacists need to consider a risk vs. benefit analysis in their patient assessments and drug therapy treatment decisions. This case highlights the debate between effective pain control and theoretical NSAID risk in a patient with possible microscopic colitis.

Schlagwörter

nonsteroidal anti-inflammatory drugsmicroscopic colitisrisk-benefit assessmentpain managementdrug safety

Zitieren

APA

Domański, N., & Gobis, B. (2023). Our Practice Newsletter : By Pharmacists For Pharmacists. Issue 32. cIRcle (University of British Columbia). https://doi.org/10.14288/1.0437498

Vancouver

Domański N, Gobis B. Our Practice Newsletter : By Pharmacists For Pharmacists. Issue 32. cIRcle (University of British Columbia). 2023. doi:10.14288/1.0437498

BibTeX
@article{Domaski2023,
  author = {Domański, Nicole and Gobis, Barbara},
  title = {Our Practice Newsletter : By Pharmacists For Pharmacists. Issue 32},
  journal = {cIRcle (University of British Columbia)},
  year = {2023},
  doi = {10.14288/1.0437498}
}
Kostenlos starten →